Skip to Content

Latest Articles

Let the Marijuana Boom Begin

Oct 17, 2018

Today’s the day. Canada is now the first industrialized nation in the world to legalize marijuana for recreational use from border to border. That puts it at the epicenter of change and growth. It also means investors have a chance to double or triple their money, perhaps even more. If you watched marijuana stocks today, you may be wondering what the heck I’m talking about. After all, they were mostly down on this historic day, some quite a bit. Actually, that’s not a surprise. October 17 has been marked on a lot of calendars for a long time, especially in Canada. It was almost like Black Friday in the U.S. Continue Reading…

3 High-Reward Stocks from 3 Emerging Trends

Oct 14, 2018

We sit on the verge of a transformation very similar to what we saw in the 1990s. Right now, there are a handful of innovations in their early stages that will change our world in the way the internet did over two decades ago. Informed investors stand to make gains similar to – and possibly even larger than – those made during the internet boom. My goal is to be one of those investors, and the key is to get in now. Today I want to tell you about three stocks, each in its own emerging trend, that have huge upside potential in the transformative years ahead. Continue Reading…

Should You Invest in PYX?

Oct 12, 2018

If you’ve never heard of Pyxus International (PYX), you are not alone. Previously known as Alliance One International, the $380 million company only recently moved onto Wall Street’s radar when it expanded outside of its central tobacco business and made a move into legal cannabis. Pyxus is big in the tobacco market, with nearly 50% of U.S. market share. But because this industry is declining globally, management made the smart decision to pivot into the emerging cannabis and hemp business. These industries happen to be some of the fastest-growing investments themes around the world. Continue Reading…

The International Conglomerate Most Folks Don’t Know About

Oct 10, 2018

Would you like to invest in a stock that gained 67,000% in the 14 years it has been publicly traded? I sure hope your answer is yes. If not, you can probably stop reading right now. Here’s another question: Would you like to invest in a stock that is down 40% over the last eight months? If your answer to that one is also yes, then…you’re right! They are actually the same company. A company that is not a household name – at least not in the United States –and yet is right smack in the middle of several of the most exciting investing themes today. Continue Reading…

5 Blue Chip Stocks to Keep an Eye On

Oct 07, 2018

Those of you who invest with me know that I love uncovering the next big thing – the stocks that are virtually unknown today but have the potential to grow into the next Facebook (FB), Amazon (AMZN) and Alphabet (GOOGL). It takes a lot of work and requires a lot of patience, but in the end it is extremely rewarding. While discovering tomorrow’s winners is my passion, I never ignore the companies that are already at the forefront of their industries yet still have plenty of upside ahead. And that’s what I want to talk about today. My research has led me to five blue-chip stocks trading at very attractive levels right now. Continue Reading…

3 Chinese Stocks to Buy Now

Oct 05, 2018

It is not uncommon for Chinese stocks to trade at a discount to their American peers, as the combination of higher perceived political and geographic risk leads to more attractive valuations. However, the recent talk of a potential trade war has these stocks trading at valuations not seen in years. I have been saying for months now that I do not believe the recent threats will escalate into a full-blown trade war, and that means that Chinese stocks are a great buying opportunity right now. Today, I’d like to introduce you to three that are especially attractive at current prices. Continue Reading…

China Stocks: Opportunity or Danger?

Oct 03, 2018

Chinese stocks have long been both fascinating and fearsome to American investors. On the one hand, it’s easy to understand the potential in a nation of 1.4 billion people, many of whom are joining the ranks of the middle class. It’s also easy to understand consistently high economic growth rates, even if they have slowed from nearly 15% 10 years ago to just under 7% today. On the other hand, risk can be higher. China is not a democracy, and the government can change things at any time. That said, this combination of higher perceived political and geographic risk often leads to attractive valuations in stocks. Continue Reading…

2 Marijuana Biotechs to Watch

Sep 30, 2018

On September 27, the United States Drug Enforcement Agency (DEA) made official a long-awaited decision on a cannabidiol (CBD)-based drug. GW Pharmaceuticals’ (GWPH) drug Epidiolex was reclassified from Schedule 1 to Schedule 5. Marijuana and hemp remain Schedule 1 drugs, but I am confident we will see a rescheduling at some point in the relatively near future. And in the meantime, I expect to see more cannabis-derived drugs receive FDA and DEA approval. There are plenty of companies out there working on cannabis-based treatment plans, but two in particular stand out to me as names worth watching right now. Continue Reading…

Best Stocks for 2018 Update: BR Keeps the Momentum Alive

Sep 28, 2018

Three months ago, I was impressed with my Best Stocks for 2018 contest pick’s 26% climb through the first six months of the year. Fast forward to three months later and it turns out that return was nothing. As we move into the fourth and final quarter of the year, my pick is now up 45%. Yes, you read that correctly. In the last three months, Broadridge Financial Solutions (BR) has nearly doubled the performance it put together through the second quarter of 2018. When you compare that to the S&P 500’s 9% gain and the less than 1% climb we’ve seen in the financial sector, BR’s trajectory stands out even more. Continue Reading…

IPOs: Profits and Perils

Sep 26, 2018

Initial public offerings have long held a certain mystique for investors, going all the way back more than 400 years to when the Dutch East India Company came the first “modern” IPO. They have even more of a mystique today in our always connected world of instant information. Some of the allure is the hope for big and fast gains, though that doesn’t always work out. We saw another example of this just today as SurveyMonkey (SVMK) made its trading debut. The stock priced its IPO at $12, opened at $18.75, got as high as $20 and closed the day at $17. One stock. One day of trading. Big difference in returns. Continue Reading…
1 2 3 25
Don't miss out on the incredible NextGen Revolution that is sweeping across our nation. Gain access to the most powerful market insights and stock advice from Matt McCall absolutely FREE. Join Today!